Literature DB >> 18466200

Elevated levels of IgG3 and IgG4 subclass in paediatric cases of kala azar.

N A Ansari1, R Kumar, A Raj, P Salotra.   

Abstract

Visceral leishmaniasis (VL) or Kala azar (KA) is a systemic disease caused by the parasites of the Leishmania donovani complex. Control measures rely on treatment with antileishmanial agents, however, fraught with problems such as toxicity or drug resistance. The incidence rate is on the rise for children, for reasons yet undefined. Previously we have shown significantly elevated level of IL-10 in children compared to adult KA cases. Here, antileishmanial antibody and C-reactive protein (CRP) levels were investigated in paediatrics and adult patients of KA and post-KA dermal leishmaniasis (PKDL). Level of IgG4 was significantly elevated in PKDL compared to KA, although total IgG and IgG1 were significantly lower. The antileishmania antibody levels of subclass IgG3 and IgG4 were found significantly elevated in paediatrics, however, levels of IgG, IgG1, IgG2 and CRP were comparable in paediatric and adult KA cases. In case of PKDL, levels of IgG and it subclass were similar in the two groups. No significant difference in antileishmanial antibody level was noticed between macular or polymorphic cases of PKDL. The differential antibody intensity in paediatric cases, together with significant level of circulating IL-10, could be considered as a marker of differential disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466200     DOI: 10.1111/j.1365-3024.2008.01036.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  5 in total

1.  Serum and salivary immunoglobulin G4 levels in children with autism spectrum disorder from south India: a case-control study.

Authors:  Sham Subraya Bhat; Bhuvanesh Sukhlal Kalal; Korikkar Mahaling Veena; Anil Kakunje; Kaupu Sathish Rao Sahana; Punchappady Devasya Rekha; Jagadish Chandra; Irshad Nasreen
Journal:  Am J Clin Exp Immunol       Date:  2021-12-15

2.  IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.

Authors:  Tapan Bhattacharyya; Armon Ayandeh; Andrew K Falconar; Shyam Sundar; Sayda El-Safi; Marissa A Gripenberg; Duncan E Bowes; Caroline Thunissen; Om Prakash Singh; Rajiv Kumar; Osman Ahmed; Osama Eisa; Alfarazdeg Saad; Sara Silva Pereira; Marleen Boelaert; Pascal Mertens; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

3.  Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis.

Authors:  Berlin Londono-Renteria; Jenny C Cardenas; Andrea Troupin; Tonya M Colpitts
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

4.  High levels of anti-Leishmania IgG3 and low CD4+ T cells count were associated with relapses in visceral leishmaniasis.

Authors:  Renata Caetano Kuschnir; Leonardo Soares Pereira; Maria Rita Teixeira Dutra; Ludmila de Paula; Maria Luciana Silva-Freitas; Gabriela Corrêa-Castro; Simone da Costa Cruz Silva; Glaucia Cota; Joanna Reis Santos-Oliveira; Alda Maria Da-Cruz
Journal:  BMC Infect Dis       Date:  2021-04-20       Impact factor: 3.090

5.  Molecular Tracking of the Leishmania Parasite.

Authors:  Srija Moulik; Shilpa Sengupta; Mitali Chatterjee
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.